BMRN FY 2012 Earnings — BioMarin Pharmaceutical Inc. Revenue & Financial Results | Market Cap Arena

BMRNBioMarin Pharmaceutical Inc.

$11B

FY 2012 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$501M+13.5% YoY

Gross Profit

$409M81.7% margin

Operating Income

-$110M-22.0% margin

Net Income

-$114M-22.8% margin

EPS (Diluted)

$-0.95

Cash Flow

Operating Cash Flow

$18M

Free Cash Flow

-$27M

Stock-Based Comp.

$47M

Balance Sheet

Total Assets

$1.6B

Total Liabilities

$553M

Stockholders' Equity

$1.0B

Cash & Equivalents

$181M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$501M	$441M	+13.5%
Gross Profit	$409M	$357M	+14.4%
Operating Income	-$110M	-$34M	-225.2%
Net Income	-$114M	-$54M	-112.4%